Re: Adjuvant Radiotherapy versus Early Salvage Radiotherapy plus Short-Term Androgen Deprivation Therapy in Men with Localised Prostate Cancer after Radical Prostatectomy (GETUG-AFU 17): A Randomised, Phase 3 Trial

被引：0
|
作者：
不详
机构：
来源：
JOURNAL OF UROLOGY | 2021年 / 205卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1225 / 1225
页数：1
相关论文
共 50 条
  • [41] Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial
    Denham, James W.
    Joseph, David
    Lamb, David S.
    Spry, Nigel A.
    Duchesne, Gillian
    Matthews, John
    Atkinson, Chris
    Tai, Keen-Hun
    Christie, David
    Kenny, Lizbeth
    Turner, Sandra
    Gogna, Nirdosh Kumar
    Diamond, Terry
    Delahunt, Brett
    Oldmeadow, Christopher
    Attia, John
    Steigler, Allison
    LANCET ONCOLOGY, 2014, 15 (10): : 1076 - 1089
  • [42] A randomised trial of short- vs long-term androgen deprivation with salvage radiotherapy for biochemical failure following radical prostatectomy: URONCOR 06-24
    Gonzalez-San Segundo, Carmen
    Campos, Fernando Lopez
    Gomez Iturriaga, Alfonso
    Rodriguez, Aurora
    Olivera, Jesus
    Duque-Santana, Victor
    Sancho, Gemma
    Henriquez, Ivan
    Conde, Antonio Jose
    Valero, Jeannette
    Maldonado, Xavier
    Glaria, Luis
    Caballero, Begona
    Sanmamed, Noelia
    Mases, Joel
    Boladeras-Inglada, Anna Maria
    Montijano, Miguel
    Santos, Marina
    Alvarez, Ana
    Martinez, Juan I.
    Counago, Felipe
    BJU INTERNATIONAL, 2024, 134 (04) : 568 - 577
  • [43] Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial
    Lane, J. Athene
    Donovan, Jenny L.
    Davis, Michael
    Walsh, Eleanor
    Dedman, Daniel
    Down, Liz
    Turner, Emma L.
    Mason, Malcolm D.
    Metcalfe, Chris
    Peters, Tim J.
    Neal, David E.
    Hamdy, Freddie C.
    LANCET ONCOLOGY, 2014, 15 (10): : 1109 - 1118
  • [44] Re: Adjuvant Versus Early Salvage Radiation Therapy After Radical Prostatectomy for pN1 Prostate Cancer and the Risk of Death
    Bello, Ana Plata
    Touijer, Karim
    EUROPEAN UROLOGY, 2023, 83 (02) : 186 - 187
  • [45] Late Toxicity and Quality of Life from GETUG-AFU 22 Study: A Multicenter Randomized Phase II Trial Comparing Radiotherapy +/-6 Months of Degarelix as a Salvage Treatment for Patients with Detectable PSA after Radical Prostatectomy
    Latorzeff, I.
    Guerif, S.
    Fraisse, J.
    Meyer, E.
    Supiot, S.
    Lagneau, E.
    Deniaud-Alexandre, E.
    Ronchin, P.
    Benyoucef, A.
    Cartier, L.
    Hamidou, H.
    Hasbini, A.
    Crehange, G.
    Pommier, P.
    Magne, N.
    Pelissier, S.
    Gross, E.
    Fourneret, P.
    Salomon, L.
    Sargos, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S134 - S134
  • [46] Kinetics of testosterone recovery in clinically localized prostate cancer patients treated with radical prostatectomy and subsequent short-term adjuvant androgen deprivation therapy
    Dai, Bo
    Qu, Yuan-Yuan
    Kong, Yun-Yi
    Ye, Ding-Wei
    Yao, Xu-Dong
    Zhang, Shi-Lin
    Zhang, Hai-Liang
    Yang, Wei-Yi
    ASIAN JOURNAL OF ANDROLOGY, 2013, 15 (04) : 466 - 470
  • [47] Anticancer Activity and Tolerance of Treatments Received Beyond Progression in Men Treated Upfront with Androgen Deprivation Therapy With or Without Docetaxel for Metastatic Castration-naive Prostate Cancer in the GETUG-AFU 15 Phase 3 Trial
    Lavaud, Pernelle
    Gravis, Gwenaelle
    Foulon, Stephanie
    Joly, Florence
    Oudard, Stephane
    Priou, Frank
    Latorzeff, Igor
    Mourey, Loic
    Soulie, Michel
    Delva, Remy
    Krakowski, Ivan
    Laguerre, Brigitte
    Theodore, Christine
    Ferrero, Jean Marc
    Beuzeboc, Philippe
    Habibian, Muriel
    Rolland, Frederic
    Deplanque, Gael
    Pouessel, Damien
    Zanetta, Sylvie
    Berdah, Jean Francois
    Dauba, Jerome
    Baciuchka, Marjorie
    Platini, Christian
    Linassier, Claude
    Tubiana-Mathieu, Nicole
    Machiels, Jean Pascal
    El Kouri, Claude
    Ravaud, Alain
    Suc, Etienne
    Eymard, Jean Christophe
    Hasbini, Ali
    Bousquet, Guilhem
    Culine, Stephane
    Boher, Jean-Marie
    Tergemina-Clain, Gabrielle
    Legoupil, Clemence
    Fizazi, Karim
    EUROPEAN UROLOGY, 2018, 73 (05) : 696 - 703
  • [48] PSA response and early PSA progression evaluated in patients randomized in a phase III trial comparing androgen deprivation therapy (ADT) plus docetaxel versus ADT alone in hormone-naive metastatic prostate cancer (GETUG-AFU 15/0403).
    Gravis, G.
    Fizazi, K.
    Joly, F.
    Oudard, S.
    Priou, F.
    Latorzeff, I.
    Delva, R.
    Esterni, B.
    Habibian, M.
    Soulie, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [49] Radiotherapy with or without short term androgen deprivation therapy in intermediate risk prostate cancer: final results of a phase III randomized trial
    Nabid, Abdenour
    Carrier, Nathalie
    Vigneault, Eric
    Thu Van Nguyen
    Vavassis, Peter
    Brassard, Marc-Andre
    Bahoric, Boris
    Archambault, Robert
    Vincent, Francois
    Bettahar, Redouane
    Wilke, Derek
    Souhami, Luis
    SCANDINAVIAN JOURNAL OF UROLOGY, 2019, 53 : 8 - 8
  • [50] Interest of short hormonotherapy (HT) associated with radiotherapy (RT) as salvage treatment for metastatic free survival (MFS) after radical prostatectomy (RP): Update at 9 years of the GETUG-AFU 16 phase III randomized trial (NCT00423475).
    Carrie, Christian
    Magne, Nicolas
    Burban-Provost, Patricia
    Sargos, Paul
    Latorzeff, Igor
    Supiot, Stephane
    Belkacemi, Yazid
    Peiffert, Didier
    Allouache, Nedla
    Dubray, Bernard M.
    Vernat, Stephanie Servagi
    Suchaud, Jean-Philippe
    Crehange, Gilles
    Guerif, Stephane
    Brihoum, Meryem
    Barbier, Nicolas
    Graff-Cailleaud, Pierre
    Ruffion, Alain
    Chabaud, Sylvie
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345